Theratechnologies Inc (FRA:TQ80)
€ 1.03 -0.02 (-1.9%) Market Cap: 52.33 Mil Enterprise Value: 69.87 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

Theratechnologies Inc Corporate Analyst Meeting Transcript

Oct 23, 2019 / 04:00PM GMT
Release Date Price: €13.04 (-3.55%)
Philippe Dubuc
Theratechnologies Inc. - Senior VP & CFO

Okay. Good afternoon, everyone. Thank you for joining us today. My name is Philippe Dubuc, Senior Vice President and Chief Financial Officer of Theratechnologies. It's a pleasure for us to welcome you today to our first R&D day, which is an opportunity for us to bring everyone up to speed on the development programs at Theratechnologies, especially in what has happened in the next -- probably in the past 6 to 9 months.

So I'll just take a moment to go through the agenda for today. We're going to start off with Luc Tanguay, who's going to say a few words. Luc, our President and CEO. Luc is going to say a few words and provide an overview of the company.

Luc will then go on to introduce Dr. Steven Grinspoon. Dr. Grinspoon is a longtime collaborator of Theratechnologies on EGRIFTA, and he will provide us with an overview of the recent study that was published on NAFLD/NASH for EGRIFTA. Dr. Grinspoon is being held up in Boston, so he'll be presenting by phone. Dr. Grinspoon is hosting a symposium this afternoon and could not

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot